Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) EVP Sells 14,790 Shares of Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) EVP Mark Stephen Katz sold 14,790 shares of Ryan Specialty stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Ryan Specialty Trading Up 0.1 %

Shares of RYAN opened at $71.72 on Thursday. The firm has a fifty day simple moving average of $68.01 and a two-hundred day simple moving average of $61.60. Ryan Specialty Holdings, Inc. has a twelve month low of $41.49 and a twelve month high of $73.10. The stock has a market capitalization of $18.78 billion, a P/E ratio of 93.14, a PEG ratio of 1.63 and a beta of 0.62. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. The company had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty’s quarterly revenue was up 20.5% on a year-over-year basis. During the same period last year, the firm earned $0.32 earnings per share. On average, research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.61%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Institutional Trading of Ryan Specialty

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RYAN. Champlain Investment Partners LLC raised its holdings in Ryan Specialty by 28.0% in the 1st quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company’s stock worth $274,022,000 after purchasing an additional 1,079,505 shares in the last quarter. Blair William & Co. IL increased its position in shares of Ryan Specialty by 3.4% during the second quarter. Blair William & Co. IL now owns 2,866,003 shares of the company’s stock valued at $165,970,000 after buying an additional 94,663 shares during the period. Bessemer Group Inc. raised its stake in Ryan Specialty by 33.9% in the first quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company’s stock worth $106,886,000 after buying an additional 488,067 shares in the last quarter. Eagle Asset Management Inc. lifted its holdings in Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after buying an additional 335,180 shares during the period. Finally, Jennison Associates LLC boosted its position in Ryan Specialty by 60.2% during the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after acquiring an additional 385,366 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. The Goldman Sachs Group lifted their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. Citigroup increased their price objective on Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research report on Tuesday, July 23rd. Barclays started coverage on Ryan Specialty in a research report on Wednesday, September 4th. They issued an “overweight” rating and a $76.00 target price for the company. Finally, UBS Group increased their price target on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research report on Tuesday, August 13th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Ryan Specialty presently has an average rating of “Hold” and a consensus price target of $70.33.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.